PubMed (MeSH Keyword) for id: 60490

Year	Number of Results
1990	3
1991	10
1992	14
1993	18
1994	10
1995	38
1996	24
1997	20
1998	25
1999	13
2000	11
2001	16
2002	9
2003	12
2004	10
2005	12
2006	6
2007	15
2008	10
2009	16
2010	9
2011	6
2012	5
2013	14
2014	8
2015	12
2016	13
2017	17
2018	11
2019	11
2020	9
2021	7
2022	6
2023	8
2024	1

1

Single and multiple inhibitors of the biosynthesis of 5-, 12-, 15-lipoxygenase products derived from cinnamyl-3,4-dihydroxy-α-cyanocinnamate: Synthesis and structure-activity relationship.

Touaibia M, Chiasson AI, Robichaud S, Doiron JA, Hébert MPA, Surette ME. Touaibia M, et al. Drug Dev Res. 2024 May;85(3):e22181. doi: 10.1002/ddr.22181. Drug Dev Res. 2024. PMID: 38619209

2

Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats.

Khare S, Jog R, Bright A, Burgess DJ, Chakder SK, Gokulan K. Khare S, et al. Nanotoxicology. 2023 Dec;17(10):583-603. doi: 10.1080/17435390.2023.2289940. Epub 2024 Jan 18. Nanotoxicology. 2023. PMID: 38146991

3

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by Betacoronavirus.

Pereira RDD, Rabelo RAN, Oliveira NFM, Porto SLT, Andrade ACDSP, Queiroz-Junior CM, Barbosa CLN, de Souza-Costa LP, Santos FRDS, Oliveira FBR, da Silva BLV, Umezu HL, Ferreira R, da Silva GSF, Cruz JS, Teixeira MM, Costa VV, Machado FS. Pereira RDD, et al. Viruses. 2023 Oct 4;15(10):2049. doi: 10.3390/v15102049. Viruses. 2023. PMID: 37896826 Free PMC article.

4

5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via β-catenin-dependent pathway.

Tang D, Hu Y, Gao W. Tang D, et al. Neurol Res. 2023 Nov;45(11):1026-1034. doi: 10.1080/01616412.2023.2255414. Epub 2023 Sep 11. Neurol Res. 2023. PMID: 37695758

5

Structure and ligand based design for identification of highly potent molecules against 5-LOX.

Kaur R, Rani S, Singh P. Kaur R, et al. Bioorg Med Chem Lett. 2023 Oct 1;94:129448. doi: 10.1016/j.bmcl.2023.129448. Epub 2023 Aug 15. Bioorg Med Chem Lett. 2023. PMID: 37591315

6

Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model.

Hudson CS, Smith JE, Eales BM, Kajiji S, Liu X, Truong LD, Tam VH. Hudson CS, et al. J Antimicrob Chemother. 2023 Oct 3;78(10):2435-2441. doi: 10.1093/jac/dkad246. J Antimicrob Chemother. 2023. PMID: 37563789

7

The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis.

Hu WM, Liu SQ, Zhu KF, Li W, Yang ZJ, Yang Q, Zhu ZC, Chang J. Hu WM, et al. Int Immunopharmacol. 2023 Aug;121:110505. doi: 10.1016/j.intimp.2023.110505. Epub 2023 Jun 20. Int Immunopharmacol. 2023. PMID: 37348233

8

Zileuton Ameliorates Neuronal Ferroptosis and Functional Recovery After Spinal Cord Injury.

Sun P, Zhou J, Zhao T, Qi H, Qian G. Sun P, et al. Altern Ther Health Med. 2023 Jul;29(5):314-319. Altern Ther Health Med. 2023. PMID: 37171943 Free article.

9

LUNG PROTECTIVE POTENTIAL EFFECT OF ZILEUTON DURING ENDOTOXAEMIA MODEL IN MALE MICE.

Alnfakh ZA, Al-Nafakh RT, Hameed AMA, Abdelhussain MA, Hadi NR. Alnfakh ZA, et al. Wiad Lek. 2022;75(12):3066-3073. doi: 10.36740/WLek202212130. Wiad Lek. 2022. PMID: 36723329

10

Structure and dynamics of 5-lipoxygenase and its complexes - a molecular dynamics simulation study.

Duran S, Moin ST. Duran S, et al. J Mol Model. 2023 Jan 21;29(2):51. doi: 10.1007/s00894-022-05434-y. J Mol Model. 2023. PMID: 36680606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

403 results

Results by year